Additionally, neutralization of IFNγ reduced intestinal disease in IL-10-/-TCRβ/δ-/- and IL-10-/- mice (Malik et al., 2014; Muraoka et al., 2021). This evidence concerns the gene IL10 and intestinal disorder.